Crowdonomics
All companies
Biotech Restorations logo

Biotech Restorations

Operating

Biotech Restorations Holdings, LLC

Biotech · Denver, NC

Post-money valuation
$4.0M
As of Nov 2017 · from Reg CF Offering (2017) · pre-money + amount raised, not a traded price
Total raised
$28,650
Across 2 rounds since 2017
Latest share price
$1.00
Reg CF Offering (2017) offering price

Financials

FY2015–FY2016 · from SEC filings · hover any figure for its source
$0
2015
$0
2016
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015
FY2016
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
4

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$4.0M
post-money
Reg CF Offering (2017)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2017)ClosedReg CF · Common Equity · via StartEngine
Raised $28.7K / $1MInvestors 51Post-money $4M
Reg CF Offering (2017-11-22)WithdrawnReg CF · Common Equity · via StartEngine
Raised $0 / $1M

Team

2 people
Chris YoungFounder
President, Founder, Managing Member

Chris is the President, Founder and Managing Member of Biotech Restorations Holdings, LLC and has been since its inception in February of 2017. He has worked in the field of industrial and agricultural chemicals and environmental remediation for 27 years. Beginning his career with Dow Chemical, Mr. Young has worked on environmental projects with the US EPA, the Department of Energy, the US Military and industrial and private clients around the world. In 2000 Mr. Young financed and co-developed a novel and proprietary biotechnology capable of eliminating persistent organic chemical pollutants, such as PCBs, dioxins, and pesticides in soil, groundwater and marine sediments. This technology sits at the core of the Biotech business model of “Green and Sustainable Environmental Remediation”. Mr. Young has designed and implemented effective, lower cost on-site soil, groundwater and sediment remediation systems for some of the country’s most toxic and polluted sites, reducing client’s cleanup costs and eliminating the client’s environmental liabilities. Mr. Young has worked in cooperation with local, state, and federal environmental regulatory agencies, multi-national construction and environmental consulting firms, and research universities on effective and innovative remediation projects. Chris is also the Founder, Managing Member and sole owner of Biotech Restorations, LLC, established in 2005, which licenses the technology to Biotech Restorations Holdings.

David FennemaFounder
CEO

Mr. Fennema is the CEO of Biotech Restorations Holdings, LLC, and has been since its inception in February of 2017. He has spent the last thirteen years in the Environmental sector, including renewable energy, wastewater/solid waste treatment and environmental finance. This phase of his career began as a Managing Director in investment banking in renewable biofuels and renewable energy. He then served as Entrepreneur in Residence for a New York based private equity firm, managing their renewable energy portfolio. From 2008 - 2010, he served as Senior Executive Vice President, Global Environment for an industrial biotechnology company. In the latter position, the company treated wastewater and contaminated soils globally, using a biological and enzymatic product. Responsibilities included travel to partners and business development in 30+ countries. Mr. Fennema is also the Founder and Managing Partner of Fenn Capital Advisors, a general business consultancy that he founded in April of 2016. David holds a Masters in Business Administration from Kellogg School of Business, Northwestern University.

Names and titles as disclosed on StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 9 annual reports (FY2017–FY2025)

Missing: 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025

51 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UApr 24, 20180001665160-18-000337
    EDGAR
  • Form C/AFeb 20, 20180001665160-18-000115
    EDGAR
  • Form C/ADec 19, 20170001665160-17-000693
    EDGAR
  • Form CNov 22, 20170001665160-17-000625
    EDGAR
  • Form C/ANov 22, 20170001665160-17-000632
    EDGAR
  • Form C-WNov 22, 20170001665160-17-000631
    EDGAR
  • Form CNov 22, 20170001665160-17-000627
    EDGAR
Source: SEC EDGARCIK 0001722316FLShare price $1.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.